EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
暂无分享,去创建一个
C. Larsson | W. Kaelin | A. von Kriegsheim | O. Surova | M. Nistér | A. Stenman | Javier Rodríguez | Isabelle Westerlund | J. Holmberg | C. Juhlin | Shuijie Li | P. Bullova | S. Schlisio | Wenyu Li | Stuart M. Fell | D. Topcic | Maria Bergsland | J. Muhr | Danijal Topcic | Jonas Muhr
[1] D. Ferguson,et al. PHD2 inactivation in Type I cells drives HIF‐2α‐dependent multilineage hyperplasia and the formation of paraganglioma‐like carotid bodies , 2018, The Journal of physiology.
[2] V. Lefebvre,et al. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. , 2017, Cancer research.
[3] O. Surova,et al. Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA , 2017, Genes & development.
[4] A. Strasser,et al. RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice , 2016, The Journal of experimental medicine.
[5] J. Cheng,et al. pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner , 2016, Science.
[6] A. von Kriegsheim,et al. Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways , 2016, Cell reports.
[7] U. Hellman,et al. The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis. , 2016, Developmental cell.
[8] G. Reifenberger,et al. Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR , 2014, Nature Communications.
[9] J. López-Barneo,et al. Deletion of the von Hippel–Lindau gene causes sympathoadrenal cell death and impairs chemoreceptor-mediated adaptation to hypoxia , 2014, EMBO molecular medicine.
[10] Jenny Welander,et al. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. , 2014, The Journal of clinical endocrinology and metabolism.
[11] C. Patterson,et al. PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. , 2012, The Journal of clinical investigation.
[12] K. Rantanen,et al. Prolyl Hydroxylase PHD3 Enhances the Hypoxic Survival and G1 to S Transition of Carcinoma Cells , 2011, PloS one.
[13] Gen Sheng Wu,et al. Bim Protein Degradation Contributes to Cisplatin Resistance* , 2011, The Journal of Biological Chemistry.
[14] William C Hahn,et al. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. , 2009, Cancer cell.
[15] Y. Guo,et al. The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMEL , 2009, Oncogene.
[16] W. Kaelin. The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer , 2008, Nature Reviews Cancer.
[17] A. Ligon,et al. A germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors , 2008, Human Genetics.
[18] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[19] M. Meyerson,et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. , 2008, Genes & development.
[20] P. Carmeliet,et al. Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3−/− Mice , 2008, Molecular and Cellular Biology.
[21] S. Signoretti,et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400 , 2008, Nature Cell Biology.
[22] A. Pause,et al. Collagen matrix assembly is driven by the interaction of von Hippel–Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2 , 2008, Oncogene.
[23] P. Ratcliffe,et al. Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor* , 2007, Journal of Biological Chemistry.
[24] W. Kaelin,et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.
[25] R. Freeman,et al. Inhibition of NGF deprivation–induced death by low oxygen involves suppression of BIMEL and activation of HIF-1 , 2005, The Journal of cell biology.
[26] G. Pagès,et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function , 2003, Oncogene.
[27] J. Pouysségur,et al. HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.
[28] P. Ratcliffe,et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.
[29] M. Ivan,et al. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.
[30] K. Moulder,et al. Induction of BIM, a Proapoptotic BH3-Only BCL-2 Family Member, Is Critical for Neuronal Apoptosis , 2001, Neuron.
[31] T. Shuin,et al. Direct interaction of the beta-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes. , 1999, Biochemical and biophysical research communications.
[32] D. Louis,et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. , 1998, Molecular cell.
[33] L. Staszewski,et al. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain , 1994, Cell.
[34] L. Staszewski,et al. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. , 1994, Cell.